Aequus Pharmaceuticals Inc. announced the addition of Dr. Vikram Lekhi, Ken Patterson, National Director of Business Development at Vision Group Canada, and an undisclosed regulatory consultant to the previously announced strategic advisory board in ophthalmology. Dr. Vikram Lekhi, Ken Patterson, and the undisclosed regulatory consultant will join the previously announced advisory board members, Dr. Rosa Braga-Mele and Dr. Ike Ahmed. Dr. Vikram Lekhi is a medical and surgical Comprehensive Ophthalmologist with a broad clinical practice, including but not limited to pediatric cases, lid lesions, meibomian gland disease, corneal dystrophies, degenerations and infections, glaucoma and retinal pathology. Dr. Lekhi regularly presents at conferences around the country and internationally. His work has appeared in various publications, such as Canadian Family Physician and BioSpectrum. Dr. Lekhi serves the rural population in Alberta through his own practice, High River Eye Surgeons. He also sees residents of Calgary as a part of the well-established Seema Eye Care Centre. Apart from his clinical and surgical duties, Dr. Lekhi is a clinical lecturer with the University of Calgary’s department of surgery. Mr. Ken Patterson is the National Director of Business Development at Vision Group Canada. Vision Group Canada oversees and manages a network of over 40 of Canada’s leading vision correction providers including LASIK MD, TLC, and the London Eye Centre. Prior to his position as National Director, Mr. Patterson dedicated over 15 years to the commercial space with Alcon, Bausch and Lomb, and Johnson and Johnson. He has built a reputation for developing business strategies and incubating new business models while remaining sensitive to supporting a positive patient experience.